Evaxion - Return on Tangible Equity 2020-2025 | EVAX

Current and historical return on tangible equity values for Evaxion - (EVAX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Evaxion - Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-06-30 $-0.02B $0.00B -184.00%
2023-06-30 $-0.03B $0.00B -123.46%
2022-06-30 $-0.02B $0.02B -101.05%
2022-03-31 $-0.03B $0.03B -107.22%
2021-12-31 $-0.02B $0.03B -96.97%
2021-09-30 $-0.02B $0.02B -108.11%
2021-06-30 $-0.02B $0.02B -133.33%
2021-03-31 $-0.02B $0.03B -182.86%
2020-12-31 $-0.02B $0.01B -857.14%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.937B 59.72
Hims & Hers Health (HIMS) United States $13.490B 140.16
Doximity (DOCS) United States $11.213B 51.91
Tempus AI (TEM) United States $10.091B 0.00
IRhythm Technologies (IRTC) United States $4.366B 0.00
Inspire Medical Systems (INSP) United States $3.822B 59.72
Hinge Health (HNGE) United States $3.402B 0.00
Privia Health (PRVA) United States $2.375B 162.33
10x Genomics (TXG) United States $1.724B 0.00
Phreesia (PHR) United States $1.614B 0.00
Enovis (ENOV) United States $1.561B 8.70
Schrodinger (SDGR) United States $1.553B 0.00
Azenta (AZTA) United States $1.553B 72.17
Clover Health Investments (CLOV) United States $1.471B 0.00
Omnicell (OMCL) United States $1.387B 24.48
Evolent Health (EVH) United States $1.105B 94.10
Claritev (CTEV) United States $0.635B 0.00
Fulgent Genetics (FLGT) United States $0.535B 0.00
Standard BioTools (LAB) United States $0.528B 0.00
Veradigm (MDRX) United States $0.503B 0.00
Butterfly Network (BFLY) United States $0.453B 0.00
Talkspace (TALK) United States $0.420B 125.50
TruBridge (TBRG) United States $0.328B 728.00
Outset Medical (OM) United States $0.311B 0.00
Health Catalyst (HCAT) United States $0.273B 0.00
Nyxoah SA (NYXH) Belgium $0.255B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.218B 0.00
CapsoVision (CV) United States $0.210B 0.00
Zepp Health (ZEPP) Netherlands $0.182B 0.00
KORU Medical Systems (KRMD) United States $0.161B 0.00
American Well (AMWL) United States $0.129B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
MDxHealth SA (MDXH) Belgium $0.117B 0.00
CareCloud (CCLD) United States $0.100B 3.82
ImmunoPrecise Antibodies (IPA) Canada $0.079B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.078B 0.00
111 (YI) China $0.060B 0.00
P3 Health Partners (PIII) United States $0.042B 0.00
HeartBeam (BEAT) United States $0.041B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Healthcare Triangle (HCTI) United States $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
PROFUSA (PFSA) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00